Integrating STING activation with programmed death-ligand 1 inhibition: Novel approaches for cancer treatment

Critical Reviews in Oncology/Hematology 2026

View at publisher

Authors: Hossein Khorramdelazad, Reyhaneh Arfaei, Pegah Yaraghi, Armin Boroumand, Abbas Kheyri, Zahra Shirzad, Farzaneh Kheiri, Vahid Bagheri

DOI: 10.1016/j.critrevonc.2026.105218

Cited by: 2

References: 223

Fields of Study & Subjects

interferon and immune responses Cancer Immunotherapy and Biomarkers Nanoplatforms for cancer theranostics

References 223